Today's Stem Cell Research

Stem Cell Research and News: Indiana

Stem Cells To Combat Peripheral Arterial Disease?

Researchers at the Indiana University School of Medicine in Indianapolis are running a study to look into the possibility of using adult stem cell injections to promote blood vessel repair and the growth of new blood vessels. The idea is...

Posted in Today's Stem Cell Research on February 27, 2006 05:04 PM

Stem Cells To Be Used To Treat Artery Disease

Indiana University School of Medicine researchers are starting a clinical trial that tests stem cells as a treatment option for peripheral artery disease. This trial involves using injections of stem cell as a treatment that could offer hope to tens...

Posted in Today's Stem Cell Research on February 9, 2006 10:13 PM

XYTOS Announces Public Listing, Trading Sector, and Future of Company

INDIANAPOLIS, Aug. 29, 2005 - XYTOS, Inc. (the "Company") (Nasdaq:XYTS) is pleased to announce their public listing under the trading symbol of XYTS. XYTOS will trade in the Bio-Medical Sector, with the goal to accelerate the future of the "Science...

Posted in Today's Stem Cell Research on September 1, 2005 07:09 PM

ThermoGenesis Corp. Initiates Shipments of Thrombin Processing Devices(TM) (TPD(TM)) To Biomet, Inc.

Agreement Allows Biomet to Immediately Market Their Gravitational Platelet Separation System (GPS) in Europe, Canada and Asia as a Fully Autologous Product RANCHO CORDOVA, Calif., Aug. 16 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL - News) announced today that the Company...

Posted in Today's Stem Cell Research on August 16, 2005 05:32 PM

Geron Announces Publication Characterizing GRN163L, Its Telomerase Inhibitor Drug Currently in Clinical Development for Cancer

MENLO PARK, Calif.--(BUSINESS WIRE)--June 1, 2005--Geron Corporation (Nasdaq:GERN) announced today the publication of data on cell and animal testing of GRN163L, its telomerase inhibitor anti-cancer drug. The results describe (1) the synthesis and structure of GRN163L, (2) its potency for...

Posted in Today's Stem Cell Research on June 3, 2005 06:48 AM

ThermoGenesis Corp. to Supply Autologous Thrombin Kits to Biomet, Inc.

RANCHO CORDOVA, Calif., April 5 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL - News) announced today that the Company and Biomet, Inc (Nasdaq: BMET - News) reached agreement for the Company to supply Biomet's subsidiary, Cell Factor Technologies, Inc. (CFT) with...

Posted in Today's Stem Cell Research on April 5, 2005 09:46 PM

Deafness Treatment Possibly on the Horizon With Stem Cells

Researchers at Indiana University School of Medicine are reportedly closer to a time when a deaf patient’s own bone marrow cells could be used to let him or her hear. The Indiana University group led by Eri Hashino, Ph.D., have...

Posted in Today's Stem Cell Research on April 4, 2005 10:55 AM

Indiana Joins Stem Cell Research Pursuit

EndGenitor Technologies, backed by angel investors and housed Downtown at the Indiana University Emerging Technologies Center incubator, plans to use stem cells from umbilical cords to repair blood vessels. EndGenitor was founded by Drs. Mervin Yoder and David Ingram, Indiana...

Posted in Today's Stem Cell Research on January 27, 2005 01:11 PM

Good News! That Fat may help your Heart!

More news on the front of stem cells being derived from the fatty tissue in ones own body, may actually be used in heart treatment. Indiana University School of Medicine researcher Dr. Keith March has hopes that this is one...

Posted in Today's Stem Cell Research on November 30, 2004 10:15 AM